- Recursion (RXRX, Financial) to announce Q1 2025 financial results on May 5, 2025, before market open.
- A live earnings call is scheduled for 8:00 am ET on the same day, with a broadcast on X, LinkedIn, and YouTube.
- Investors and analysts can participate by submitting questions online ahead of the call.
Recursion (RXRX), a prominent clinical stage TechBio company, is set to disclose its business updates and financial results for the first quarter of 2025 on Monday, May 5, 2025, prior to the opening of the financial markets. Interested parties can anticipate accessing the detailed report early in the day, setting the tone for market activities.
The company has scheduled a live earnings call to be held later that day at 8:00 am Eastern Time (ET), 6:00 am Mountain Time (MT), and 1:00 pm Greenwich Mean Time (GMT). The live broadcast will be accessible across multiple social media platforms, including X (formerly Twitter), LinkedIn, and YouTube, providing stakeholders with an opportunity to get insights directly from the company's leadership.
In an effort to engage with its investor community, Recursion is allowing investors and analysts to submit questions through a dedicated online form. This interactive session aims to enhance transparency and provide clarity on the company’s performance and future prospects.
Recursion, headquartered in Salt Lake City, is known for its pioneering work in decoding biology through its advanced platform, the Recursion OS. The company combines technology, biology, and chemistry to accelerate the development of medical treatments, positioning itself as a leader in the TechBio space.
